1. Edoxaban treatment in real-world practice is highly concordant with ESC atrial fibrillation guidelines: results from the non-interventional global ETNA-AF program. (14th October 2021) Authors: Morrone, D; Chen, C; Dinshaw, L; Jiang, W; Kim, Y.-H; Kirchhof, P; Koretsune, Y; Pecen, L; Reimitz, P.-E; Wang, C.-C; Yamashita, T; Unverdorben, M; De Caterina, R Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effectiveness and safety of edoxaban in atrial fibrillation patients from the ETNA-AF global registry. (14th October 2021) Authors: De Caterina, R; Wang, R; Shi, L; Pecen, L; Ye, X; Reimitz, P.-E; Chen, C; Unverdorben, M; Giugliano, R.P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Temporal trend of clinical events in patients with atrial fibrillation on edoxaban therapy: results from the non-interventional global ETNA-AF program. (14th October 2021) Authors: Dinshaw, L; Chen, C; De Caterina, R; Jiang, W; Kim, Y.-H; Koretsune, Y; Morrone, D; Pecen, L; Reimitz, P.-E; Wang, C.-C; Yamashita, T; Unverdorben, M; Kirchhof, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗